Public Meeting of the Presidential Commission for the Study of Bioethical Issues, 44978-44979 [2015-18443]
Download as PDF
<![CDATA[
44978
Federal Register / Vol. 80, No. 144 / Tuesday, July 28, 2015 / Notices
The meeting will be held on
Tuesday, August 18, 2015, from 9:00
a.m. until 5:00 p.m., ET and
Wednesday, August 19, 2015, from 9:00
a.m. until 5:00 p.m., ET.
ADDRESSES: Department of Health and
Human Services, Hubert H. Humphrey
Building, 200 Independence Avenue
SW., Room 800, Washington, DC 20201.
For a map and directions to the Hubert
H. Humphrey building, please refer to
https://www.hhs.gov/about/hhh.html.
FOR FURTHER INFORMATION CONTACT: Any
questions about meeting registration or
public comment sign-up should be
directed to CFSACmtg@hhs.gov. Please
direct other inquiries to CFSAC@
hhs.gov.
SUPPLEMENTARY INFORMATION: CFSAC
was established on September 5, 2002 to
advise, consult with, and make
recommendations to the Secretary,
through the Assistant Secretary for
Health, on a broad range of topics
including: (1) The current state of
knowledge and research and the
relevant gaps in knowledge and research
about the epidemiology, etiologies,
biomarkers, and risk factors relating to
myalgic encephalomyelitis/chronic
fatigue syndrome (ME/CFS), and
identifying potential opportunities in
these areas; (2) impact and implications
of current and proposed diagnosis and
treatment methods for ME/CFS; (3)
development and implementation of
programs to inform the public, health
care professionals, and the biomedical
research communities about ME/CFS
advances; and (4) strategies to improve
the quality of life of ME/CFS patients.
The agenda for this meeting is being
developed and will be posted on the
CFSAC Web site, https://www.hhs.gov/
advcomcfs/ when finalized. The
meeting will be live-video streamed at
https://www.hhs.gov/live and archived
through the CFSAC Web site: https://
www.hhs.gov/advcomcfs/. Listeningonly via telephone will be available on
both days. Call-in information will be
posted on the CFSAC Web site.
Individuals who plan to attend inperson on one or both days will need to
register in advance so that information
can be provided to government security
officials to facilitate entrance to the
building. A registration form should be
downloaded from the CFSAC Web site
(https://www.hhs.gov/advcomcfs/),
completed, and emailed to CFSACmtg@
hhs.gov to facilitate entrance through
building security. Registration will be
open on July 27, 2015. All registration
should be completed by August 13,
2015. Using the same process as above,
members of the media will need to
register at CFSACmtg@hhs.gov. All
asabaliauskas on DSK5VPTVN1PROD with NOTICES
DATES:
VerDate Sep<11>2014
19:17 Jul 27, 2015
Jkt 235001
attendees will be required to show valid
government-issued picture
identification (state or federal) for entry
into the federal building. Attendees will
receive a wrist band that must be worn
the entire time. Security requires all
non-federal employees to be escorted
the entire time they are in the building.
Upon leaving the building for any
reason, persons will be required to
follow the security steps mentioned
above and receive a new wrist band.
Attendance by visitors who are not
U.S. citizens is welcome, but prior
approval is required. A form for nonU.S. citizens can be downloaded from
the CFSAC Web site (https://
www.hhs.gov/advcomcfs/), completed,
and emailed to CFSACmtg@hhs.gov
before August 1, 2015.
Members of the public will have the
opportunity to provide public comment
at the meeting or via telephone.
International calls cannot be
accommodated. Individuals wishing to
provide public comment in-person or
via phone will be required to request
time for public comment by Monday,
August 10, 2015 at the following link:
CFSACmtg@hhs.gov. An email will be
sent by August 13, 2015 to confirm an
individual’s time for public comment.
Each speaker will be limited to three
minutes for public comment. No
exceptions will be made. Priority will be
given to individuals who have not
provided public comment within the
previous year.
You are not required to submit a
written copy of your testimony unless
you wish to have it included in the
public record. Individuals wishing to
submit written comment for the public
record should send an electronic copy
of their written testimony to:
CFSACmtg@hhs.gov by August 13, 2015.
The document for public record must
not exceed 5 single-spaced, typed pages,
using a 12-point typeface; it is preferred
that the document be prepared in the
MS Word format. Please note that PDF
files, hand-written notes, charts, and
photographs will not be posted on the
CFSAC Web site.
Requests to participate in the public
comment and provide written testimony
will not be accepted at CFSAC@hhs.gov.
Please send all questions about public
comment requests or inquiries to
CFSACmtg@hhs.gov.
Only written testimony submitted for
public record and received by August
13, 2015 are part of the official meeting
record; this testimony will be posted to
the CFSAC Web site within 60 days
after the meeting. Materials submitted
should not include sensitive personal
information, such as social security
number, birthdates, driver’s license
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
number, state identification or foreign
country equivalent, passport number,
financial account number, credit or
debit card number. If you wish to
remain anonymous the document must
specify this.
Persons who wish to distribute
printed materials in person (at their own
expense) to CFSAC members during the
meeting should submit one copy for
approval to the Designated Federal
Officer at CFSACmtg@hhs.gov, prior to
August 13, 2015.
Dated: July 17, 2015.
Nancy C. Lee,
Designated Federal Officer, Chronic Fatigue
Syndrome Advisory Committee.
[FR Doc. 2015–18444 Filed 7–27–15; 8:45 am]
BILLING CODE 4150–42–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Public Meeting of the Presidential
Commission for the Study of
Bioethical Issues
Presidential Commission for
the Study of Bioethical Issues, Office of
the Assistant Secretary for Health,
Office of the Secretary, Department of
Health and Human Services.
ACTION: Notice of meeting.
AGENCY:
The Presidential Commission
for the Study of Bioethical Issues (the
Commission) will conduct its twenty
second meeting on September 2, 2015.
At this meeting, the Commission will
continue to discuss the role of
deliberation and deliberative methods to
engage the public and inform
consideration in bioethics, and how to
integrate pubic dialogue into the
bioethics conversation; bioethics
education as a forum for fostering
deliberative skills, and preparing
students to participate in public
dialogue in bioethics; goals and
methods of bioethics education; and
integrating bioethics education across a
range of professional disciplines and
educational levels.
DATES: The meeting will take place on
September 2, 2015, from 9 a.m. to
approximately 5 p.m.
ADDRESSES: Renaissance Washington
Hotel, 999 9th Street NW., Washington,
DC 20001.
FOR FURTHER INFORMATION CONTACT: Lisa
M. Lee, Executive Director, Presidential
Commission for the Study of Bioethical
Issues, 1425 New York Avenue NW.,
Suite C–100, Washington, DC 20005.
Telephone: 202–233–3960. Email:
Lisa.Lee@bioethics.gov. Additional
information may be obtained at
www.bioethics.gov.
SUMMARY:
E:\FR\FM\28JYN1.SGM
28JYN1
Federal Register / Vol. 80, No. 144 / Tuesday, July 28, 2015 / Notices
Pursuant
to the Federal Advisory Committee Act
of 1972, Public Law 92–463, 5 U.S.C.
app. 2, notice is hereby given of the
twenty second meeting of the
Commission. The meeting will be open
to the public with attendance limited to
space available. The meeting will also
be webcast at www.bioethics.gov.
Under authority of Executive Order
13521, dated November 24, 2009, the
President established the Commission.
The Commission is an expert panel of
not more than 13 members who are
drawn from the fields of bioethics,
science, medicine, technology,
engineering, law, philosophy, theology,
or other areas of the humanities or
social sciences. The Commission
advises the President on bioethical
issues arising from advances in
biomedicine and related areas of science
and technology. The Commission seeks
to identify and promote policies and
practices that ensure scientific research,
health care delivery, and technological
innovation are conducted in a socially
and ethically responsible manner.
The main agenda items for the
Commission’s twenty second meeting
are to continue discussing the role of
deliberation and deliberative methods to
engage the public in bioethics, and how
to integrate pubic dialogue into the
bioethics conversation; bioethics
education as a forum for fostering
deliberative skills, and preparing
students to participate in public
dialogue in bioethics; goals and
methods of bioethics education; and
integrating bioethics education across a
range of professional disciplines and
educational levels. The draft meeting
agenda and other information about the
Commission, including information
about access to the webcast, will be
available at www.bioethics.gov.
The Commission welcomes input
from anyone wishing to provide public
comment on any issue before it.
Respectful consideration of opposing
views and active participation by
citizens in public exchange of ideas
enhances overall public understanding
of the issues at hand and conclusions
reached by the Commission. The
Commission is particularly interested in
receiving comments and questions
during the meeting that are responsive
to specific sessions. Written comments
will be accepted at the registration desk
and comment forms will be provided to
members of the public in order to write
down questions and comments for the
Commission as they arise. To
accommodate as many individuals as
possible, the time for each question or
comment may be limited. If the number
of individuals wishing to pose a
asabaliauskas on DSK5VPTVN1PROD with NOTICES
SUPPLEMENTARY INFORMATION:
VerDate Sep<11>2014
19:17 Jul 27, 2015
Jkt 235001
question or make a comment is greater
than can reasonably be accommodated
during the scheduled meeting, the
Commission may make a random
selection.
Written comments will also be
accepted in advance of the meeting and
are especially welcome. Please address
written comments by email to info@
bioethics.gov, or by mail to the
following address: Public Commentary,
Presidential Commission for the Study
of Bioethical Issues, 1425 New York
Avenue NW., Suite C–100, Washington,
DC 20005. Comments will be publicly
available, including any personally
identifiable or confidential business
information that they contain. Trade
secrets should not be submitted.
Anyone planning to attend the
meeting who needs special assistance,
such as sign language interpretation or
other reasonable accommodations,
should notify Esther Yoo by telephone
at (202) 233–3960, or email at
Esther.Yoo@bioethics.gov in advance of
the meeting. The Commission will make
every effort to accommodate persons
who need special assistance.
Dated: July 15, 2015.
Lisa M. Lee,
Executive Director, Presidential Commission
for the Study of Bioethical Issues.
[FR Doc. 2015–18443 Filed 7–27–15; 8:45 am]
BILLING CODE 4154–06–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the Presidential Advisory
Council on HIV/AIDS
Office of the Assistant
Secretary for Health, Office of the
Secretary, Department of Health and
Human Services.
ACTION: Notice.
AGENCY:
As stipulated by the Federal
Advisory Committee Act, the U.S.
Department of Health and Human
Service is hereby giving notice that the
Presidential Advisory Council on HIV/
AIDS (PACHA) will be holding a
meeting to continue discussions and
possibly develop recommendations
regarding People Living with HIV/AIDS.
PACHA members will hear panels on
performance measures, HIV and the
youth, the National AIDS Housing
Coalition and other issues related to
people living with HIV. Additionally,
PACHA members will discuss the
updated National HIV/AIDS Strategy.
The meeting will be open to the public.
DATES: The meeting will be held on
September 15, 2015, from 9:00 a.m. to
approximately 5:00 p.m. (ET) and
SUMMARY:
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
44979
September 16, 2015, from 9:00 a.m. to
approximately 12:30 p.m. (ET).
ADDRESSES: The Ronald Reagan
Building and International Trade Center
is located at 1300 Pennsylvania Ave.
NW., Washington, DC 20004.
FOR FURTHER INFORMATION CONTACT: Ms.
Caroline Talev, Public Health Analyst,
Presidential Advisory Council on HIV/
AIDS, U.S. Department of Health and
Human Services, 200 Independence
Avenue SW., Room 443H, Washington,
DC 20201; (202) 205–1178. More
detailed information about PACHA can
be obtained by accessing the PACHA
Web page on the AIDS.Gov Web site at
www.aids.gov/pacha.
SUPPLEMENTARY INFORMATION: PACHA
was established by Executive Order
12963, dated June 14, 1995, as amended
by Executive Order 13009, dated June
14, 1996. The Council was established
to provide advice, information, and
recommendations to the Secretary
regarding programs and policies to
promote effective prevention and cure
of HIV disease and AIDS. The functions
of the Council are solely advisory in
nature.
The Council consists of not more than
25 members. Council members are
selected from prominent community
leaders with particular expertise in, or
knowledge of, matters concerning HIV
and AIDS, public health, global health,
philanthropy, marketing or business, as
well as other national leaders held in
high esteem from other sectors of
society. Council members are appointed
by the Secretary or designee, in
consultation with the White House
Office on National AIDS Policy. The
agenda for the upcoming meeting will
be posted on the AIDS.gov Web site at
www.aids.gov/pacha.
Public attendance at the meeting is
limited to space available. Individuals
who plan to attend and need special
assistance, such as sign language
interpretation or other reasonable
accommodations, should notify Caroline
Talev at caroline.talev@hhs.gov. Due to
space constraints, pre-registration for
public attendance is advisable and can
be accomplished by contacting Caroline
Talev at caroline.talev@hhs.gov by close
of business on September 8, 2015.
Members of the public will have the
opportunity to provide comments at the
meeting. Any individual who wishes to
participate in the public comment
session must register with Caroline
Talev at caroline.talev@hhs.gov by close
of business on September 8, 2015;
registration for attending the meeting
and/or participating in the public
comment session will not be accepted
by telephone. Individuals are
E:\FR\FM\28JYN1.SGM
28JYN1
]]>Agencies
[Federal Register Volume 80, Number 144 (Tuesday, July 28, 2015)]
[Notices]
[Pages 44978-44979]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-18443]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Public Meeting of the Presidential Commission for the Study of
Bioethical Issues
AGENCY: Presidential Commission for the Study of Bioethical Issues,
Office of the Assistant Secretary for Health, Office of the Secretary,
Department of Health and Human Services.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: The Presidential Commission for the Study of Bioethical Issues
(the Commission) will conduct its twenty second meeting on September 2,
2015. At this meeting, the Commission will continue to discuss the role
of deliberation and deliberative methods to engage the public and
inform consideration in bioethics, and how to integrate pubic dialogue
into the bioethics conversation; bioethics education as a forum for
fostering deliberative skills, and preparing students to participate in
public dialogue in bioethics; goals and methods of bioethics education;
and integrating bioethics education across a range of professional
disciplines and educational levels.
DATES: The meeting will take place on September 2, 2015, from 9 a.m. to
approximately 5 p.m.
ADDRESSES: Renaissance Washington Hotel, 999 9th Street NW.,
Washington, DC 20001.
FOR FURTHER INFORMATION CONTACT: Lisa M. Lee, Executive Director,
Presidential Commission for the Study of Bioethical Issues, 1425 New
York Avenue NW., Suite C-100, Washington, DC 20005. Telephone: 202-233-
3960. Email: Lisa.Lee@bioethics.gov. Additional information may be
obtained at www.bioethics.gov.
[[Page 44979]]
SUPPLEMENTARY INFORMATION: Pursuant to the Federal Advisory Committee
Act of 1972, Public Law 92-463, 5 U.S.C. app. 2, notice is hereby given
of the twenty second meeting of the Commission. The meeting will be
open to the public with attendance limited to space available. The
meeting will also be webcast at www.bioethics.gov.
Under authority of Executive Order 13521, dated November 24, 2009,
the President established the Commission. The Commission is an expert
panel of not more than 13 members who are drawn from the fields of
bioethics, science, medicine, technology, engineering, law, philosophy,
theology, or other areas of the humanities or social sciences. The
Commission advises the President on bioethical issues arising from
advances in biomedicine and related areas of science and technology.
The Commission seeks to identify and promote policies and practices
that ensure scientific research, health care delivery, and
technological innovation are conducted in a socially and ethically
responsible manner.
The main agenda items for the Commission's twenty second meeting
are to continue discussing the role of deliberation and deliberative
methods to engage the public in bioethics, and how to integrate pubic
dialogue into the bioethics conversation; bioethics education as a
forum for fostering deliberative skills, and preparing students to
participate in public dialogue in bioethics; goals and methods of
bioethics education; and integrating bioethics education across a range
of professional disciplines and educational levels. The draft meeting
agenda and other information about the Commission, including
information about access to the webcast, will be available at
www.bioethics.gov.
The Commission welcomes input from anyone wishing to provide public
comment on any issue before it. Respectful consideration of opposing
views and active participation by citizens in public exchange of ideas
enhances overall public understanding of the issues at hand and
conclusions reached by the Commission. The Commission is particularly
interested in receiving comments and questions during the meeting that
are responsive to specific sessions. Written comments will be accepted
at the registration desk and comment forms will be provided to members
of the public in order to write down questions and comments for the
Commission as they arise. To accommodate as many individuals as
possible, the time for each question or comment may be limited. If the
number of individuals wishing to pose a question or make a comment is
greater than can reasonably be accommodated during the scheduled
meeting, the Commission may make a random selection.
Written comments will also be accepted in advance of the meeting
and are especially welcome. Please address written comments by email to
info@bioethics.gov, or by mail to the following address: Public
Commentary, Presidential Commission for the Study of Bioethical Issues,
1425 New York Avenue NW., Suite C-100, Washington, DC 20005. Comments
will be publicly available, including any personally identifiable or
confidential business information that they contain. Trade secrets
should not be submitted.
Anyone planning to attend the meeting who needs special assistance,
such as sign language interpretation or other reasonable
accommodations, should notify Esther Yoo by telephone at (202) 233-
3960, or email at Esther.Yoo@bioethics.gov in advance of the meeting.
The Commission will make every effort to accommodate persons who need
special assistance.
Dated: July 15, 2015.
Lisa M. Lee,
Executive Director, Presidential Commission for the Study of Bioethical
Issues.
[FR Doc. 2015-18443 Filed 7-27-15; 8:45 am]
BILLING CODE 4154-06-P
